Patent Application
Utility
App. No. 15/969,500
· Confirmation No. 3186
EPINEPHRINE FORMULATIONS
Applicant:
PAR PHARMACEUTICAL, INC.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2019-03-15 | ABN |
Abandonment | 2 | View | |
| 2019-01-25 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2019-01-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2018-09-12 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 3 | View | |
| 2018-09-12 | FOR |
Foreign Reference | 40 | View | |
| 2018-09-12 | FOR |
Foreign Reference | 1 | View | |
| 2018-09-12 | FOR |
Foreign Reference | 31 | View | |
| 2018-09-12 | FOR |
Foreign Reference | 55 | View | |
| 2018-09-12 | FOR |
Foreign Reference | 55 | View | |
| 2018-09-12 | FOR |
Foreign Reference | 22 | View | |
| 2018-09-12 | FOR |
Foreign Reference | 35 | View | |
| 2018-09-12 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2018-09-12 | TRAN.LET |
Transmittal Letter | 3 | View | |
| 2018-09-06 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2018-08-08 | CTNF |
Non-Final Rejection | 10 | View | |
| 2018-08-08 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2018-08-08 | 1449 |
List of References cited by applicant and considered by examiner | 2 | View | |
| 2018-08-08 | SRNT |
Examiner's search strategy and results | 11 | View | |
| 2018-08-08 | SRNT |
Examiner's search strategy and results | 8 | View | |
| 2018-08-08 | 1449 |
List of References cited by applicant and considered by examiner | 2 | View | |
| 2018-08-08 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2018-06-06 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2018-06-05 | TRACK1.GRANT |
Track One request Granted | 2 | View | |
| 2018-05-31 | CFILE |
Request for Corrected Filing Receipt | 5 | View | |
| 2018-05-31 | ADS |
Application Data Sheet | 9 | View | |
| 2018-05-31 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2018-05-30 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2018-05-30 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2018-05-25 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 2 | View | |
| 2018-05-25 | TRAN.LET |
Transmittal Letter | 3 | View | |
| 2018-05-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2018-05-02 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View | |
| 2018-05-02 | TRACK1.REQ |
Track One Request | 2 | View | |
| 2018-05-02 | OATH |
Oath or Declaration filed | 3 | View | |
| 2018-05-02 | PA.. |
Power of Attorney | 2 | View | |
| 2018-05-02 | TRAN.LET |
Transmittal Letter | 3 | View | |
| 2018-05-02 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 2 | View | |
| 2018-05-02 | DRW.NONBW |
Drawings-other than black and white line drawings | 6 | View | |
| 2018-05-02 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2018-05-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 4 | View | |
| 2018-05-02 | SPEC |
Specification | 77 | View | |
| 2018-05-02 | CLM |
Claims | 3 | View | |
| 2018-05-02 | ABST |
Abstract | 1 | View | |
| 2018-05-02 | ADS |
Application Data Sheet | 9 | View | |
| 2018-05-02 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View |
Inventors
Attorneys & Agents of Record
Classification
USPC
514/653
A61K31/137
A61K9/0014
A61K9/0019
A61K9/0048
A61K9/0073
A61K9/08
A61K47/12
A61K47/20
Prosecution
- Examiner
- STRONG, TORI
- Art Unit
- 1629
- Customer No.
- 4372
- Docket No.
- 027273.00272
- Confirmation No.
- 3186
Publication
- Pub. No.
- US20180250245A1
- Pub. Date
- 2018-09-06
Parent
is a Continuation of
→
App. 15/455,991
Filed 2017-03-10
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation in-part of
→
App. 14/863,112
· US 10,130,592
Filed 2015-09-23
· Patented Case
Parent
is a Continuation of
→
App. 14/818,121
· US 9,295,657
Filed 2015-08-04
· Patented Case
Parent
is a Continuation of
→
App. 14/657,990
· US 9,119,876
Filed 2015-03-13
· Patented Case
Child
is a Continuation of
→
App. 16/817,253
· US 11,337,938
Filed 2020-03-12
· Patented Case
Child
is a Continuation of
→
App. 17/685,090
· US 12,440,458
Filed 2022-03-02
· Patented Case
Child
is a Continuation of
→
App. 19/398,226
Filed 2025-11-24
· Docketed New Case - Ready for Examination
Child
is a Continuation of
→
App. 18/470,256
Filed 2023-09-19
· Abandoned -- Failure to Respond to an Office Action
Child
is a Continuation of
→
App. 18/477,161
· US 12,280,024
Filed 2023-09-28
· Patented Case
Child
is a Continuation of
→
App. 16/258,204
· US 10,624,864
Filed 2019-01-25
· Patented Case
Child
is a Continuation of
→
App. 19/393,720
Filed 2025-11-19
· Docketed New Case - Ready for Examination
ACTIENT PHARMACEUTICALS LLC,
ASTORA WOMEN’S HEALTH HOLDINGS, LLC,
ASTORA WOMEN’S HEALTH LLC,
AUXILIUM PHARMACEUTICALS, LLC,
AUXILIUM US HOLDINGS, LLC,
BIOSPECIFICS TECHNOLOGIES CORP.,
BIOSPECIFICS TECHNOLOGIES LLC,
DAVA INTERNATIONAL, LLC,
DAVA PHARMACEUTICALS, LLC,
ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.),
ENDO PHARMACEUTICALS INC.,
ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.),
GENERICS BIDCO I, LLC,
GENERICS INTERNATIONAL (US), INC.,
PAR PHARMACEUTICAL, INC.,
PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC),
QUARTZ SPECIALTY PHARMACEUTICALS, LLC,
SLATE PHARMACEUTICALS, LLC,
VINTAGE PHARMACEUTICALS, LLC
RELEASE OF SECURITY INTEREST
Recorded 2024-04-26
ACTIENT PHARMACEUTICALS LLC,
ASTORA WOMEN’S HEALTH LLC,
AUXILIUM PHARMACEUTICALS, LLC,
AUXILIUM US HOLDINGS, LLC,
BIOSPECIFICS TECHNOLOGIES CORP.,
BIOSPECIFICS TECHNOLOGIES LLC,
DAVA INTERNATIONAL, LLC,
DAVA PHARMACEUTICALS, LLC,
ENDO PHARMACEUTICALS INC.,
ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.),
GENERICS BIDCO I, LLC,
GENERICS INTERNATIONAL (US), INC.,
PAR PHARMACEUTICAL, INC.,
PAR PHARMACEUTICAL COMPANIES, INC.,
PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC),
QUARTZ SPECIALTY PHARMACEUTICALS, LLC,
SLATE PHARMACEUTICALS, LLC,
VINTAGE PHARMACEUTICALS, LLC
RELEASE OF SECURITY INTEREST
Recorded 2024-04-25
from
ASTORA WOMEN'S HEALTH LLC,
ENDO PHARMACEUTICALS INC.,
ENDO PHARMACEUTICALS SOLUTIONS INC.,
PAR PHARMACEUTICAL, INC.
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS
Recorded 2021-09-17
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2018-05-07
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 15/969,500
- Filed
- 2018-05-02
- Pub. No.
- US20180250245A1
- Examiner
- STRONG, TORI
- Art Unit
- 1629
External Links